The Refractory Follicular Lymphoma (RFL) Diagnostics Market is poised for steady growth during the forecast period of 2025-2029, with a projected compound annual growth rate (CAGR) of 5.14%. In 2023, the market was valued at USD 345.81 million and is expected to reach USD 464.47 million by 2029, driven by advancements in diagnostic technologies and the rising prevalence of refractory follicular...